Clinical experience with the use and efficacy evaluation of new Insacar Total C Plus for dogs and Insacar Total K Plus for cats

The purpose of the research is to study the efficacy of new multicomponent drugs for dogs and cats against arachnoentomosis and helminthosis.Materials and methods. The efficacy of new four-component Insacar Total C Plus Drops for Dogs and Insacar Total K Plus Drops for Cats was studied on target animal species. The experiment included 90 dogs and 82 cats including 38 dogs and 37 cats with monoinfection by ticks (Sarcoptes canis, Demodex canis, Notoedres cati, Otodectes cynotis, family Ixodidae), 39 dogs and 31 cats with monoinfection by insects (Ctenocephalides sp., Linognathus setosus, Trichodectes canis), 13 dogs and 14 cats with infection by helminths (Toxocara canis, T. cati, Toxascaris leonina, Taenia sp.), and 13 dogs and 10 cats with mixed infections. The drug was applied to the skin of the animals in dosages as specified in the instructions for use. The therapy effectiveness was monitored on days 14 and 28, and in case of Notoedres cati and Sarcoptes canis, on day 40.Results and discussion. The efficacy of multicomponent drugs against monoinfections with insects, ixodid ticks, ticks of the genus Demodex and helminths, as well as mixed infections of the dogs and cats was 100% in clinical studies. The efficacy in the cats with notoedric mange was 80%, and 83.4% in the dogs with sarcoptic mange. The advantage of four-component Insacar Total C Plus Drops for Dogs and Insacar Total K Plus Drops for Cats is the presence of several components, namely, imidacloprid, praziquantel, pyriproxyfen, and moxidectin. The unique combination of active ingredients ensures the efficacy of drugs against external and internal parasites including ixodid ticks, and preventive efficacy against entomosis and ixodid ticks for 30 days. The drops for dogs and cats are advisable against mixed infections.